Our May issue is live! Featuring an Editorial on & trials in and paroxysmal nocturnal haemoglobinuria, a review of polyclonal hypergammaglobulinaemia, and more.
https://t.co/EyrqUdHpyd

23 50

The in "Targeting thrombin, coagulation factor Xa, or PAR-1, might be an attractive approach to reduce microthrombosis, lung injury, and associated poor outcomes"

NEW Correspondence https://t.co/O20XH4JCIP from R Jose & A Manuel

84 110